Hepatic steatosis and hepatic fibrosis are negatively associated with IGF1 (10,11,14,44,41) and IGF1/IGFBP3 ratio (41,46), while positively associated with IGFBP3 (47,48). The gene discussed is IGFBP3; the disease is fatty liver disease.